{"pub": "marketwatch", "url": "https://wsj.com/articles/regulators-wonder-if-cancer-patients-need-new-treatments-11572475291", "downloaded_at": "2019-10-30 23:22:53.902286+00:00", "title": "Regulators Wonder if Cancer Patients \u2018Need\u2019 New Treatments", "language": "en", "text": "Breakthroughs against cancer are devilishly hard to come by, as millions of Americans learn firsthand each year. Yet regulators in one state want to use an outdated law to bar desperate cancer patients from the latest hard-won treatment.\n\nThe new therapy is called CAR-T, short for chimeric antigen receptor T-cells. A doctor removes the patient\u2019s own T-cells\u2014a type of immune-system cell\u2014sends them off to a laboratory to be converted into cancer-fighting cells, and reinjects them into the patient. The Food and Drug Administration...", "description": "Michigan hospitals may spend years seeking approval for a therapy already endorsed by the FDA.", "authors": ["Matthew Mitchell", "Anna Parsons"], "top_image": "https://images.wsj.net/im-121320/social", "published_at": "2019-10-30"}